Abstract
The increasing prevalence of non communicable diseases (NCDs) poses main challenges to global public health. Various environmental exposures to different chemicals and pollutants might interact with genetic and epigenetic mechanisms resulting in the development of NCDs. Among these environmental exposures, endocrine disrupting chemicals (EDCs) consist of a group of compounds with potential adverse health effects and the interference with the endocrine system. They are mostly used in food constituents, packaging industries and pesticides. Growing number of in vitro, in vivo, and epidemiological studies documented the link of EDC exposure with obesity, diabetes, and metabolic syndrome, which are the underlying factors for development of NCDs. Prevention of exposure to EDCs and reduction of their production should be underscored in strategies for primordial prevention of NCDs.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Erkekoglu P, Kocer-Gumusel B (2016) Environmental effects of endocrine-disrupting chemicals: a special focus on phthalates and bisphenol A. Environmental health risk-hazardous factors to living species. InTech
Besbelli N, Zastenskaya I (2014) Identification of risks from exposure to endocrine disrupting chemicals at the country level. World health organization, Geneva
Birnbaum LS (2013) When environmental chemicals act like uncontrolled medicine. Trends Endocrinol Metab 24(7):321–323
Moosa A, Shu H, Sarachana T, Hu VW (2017) Are endocrine disrupting compounds environmental risk factors for autism spectrum disorder? Horm Behav 101:13–21
Giulivo M, de Alda ML, Capri E, Barceló D (2016) Human exposure to endocrine disrupting compounds: their role in reproductive systems, metabolic syndrome and breast cancer. A review. Environ Res 151:251–264
Teitelbaum SL, Mervish N, Moshier EL, Vangeepuram N, Galvez MP, Calafat AM et al (2012) Associations between phthalate metabolite urinary concentrations and body size measures in New York City children. Environ Res 112:186–193
Botton J, Kadawathagedara M, de Lauzon-Guillain B (eds) (2017) Endocrine disrupting chemicals and growth of children. Annales d’endocrinologie, Elsevier
WHO (2014) Global status report on noncommunicable diseases 2014: attaining the nine global noncommunicable diseases targets; a shared responsability. Global status report on noncommunicable diseases 2014: attaining the nine global noncommunicable diseases targets; a shared responsability
Hanson M, Godfrey KM, Lillycrop KA, Burdge GC, Gluckman PD (2011) Developmental plasticity and developmental origins of non-communicable disease: theoretical considerations and epigenetic mechanisms. Prog Biophys Mol Biol 106(1):272–280
World Health Organization (WHO) (2017) Preventing noncommunicable diseases (NCDs) by reducing environmental risk factors. WHO, Geneva
Walls KL, Boulic M, Boddy JW (2016) The built environment – a missing “cause of the causes” of non-communicable diseases. Int J Environ Res Public Health 13(10):956
Godfrey KM, Gluckman PD, Hanson MA (2010) Developmental origins of metabolic disease: life course and intergenerational perspectives. Trends Endocrinol Metab 21(4):199–205
Piler P, Kandrnal V, Bláha L (2017) Critical assessment of the research outcomes of European birth cohorts: linking environmental factors with non-communicable diseases. Public Health 145:136–145
Pirard C, Compere S, Firquet K, Charlier C (2018) The current environmental levels of endocrine disruptors (mercury, cadmium, organochlorine pesticides and PCBs) in a Belgian adult population and their predictors of exposure. Int J Hyg Environ Health 221(2):211–222
Xue J, Wu Q, Sakthivel S, Pavithran PV, Vasukutty JR, Kannan K (2015) Urinary levels of endocrine-disrupting chemicals, including bisphenols, bisphenol A diglycidyl ethers, benzophenones, parabens, and triclosan in obese and non-obese Indian children. Environ Res 137:120–128
Helaleh M, Diboun I, Altamimi N, Al-Sulaiti H, Al Emadi M, Madani A et al (2018) Association of polybrominated diphenyl ethers in two fat compartments with increased risk of insulin resistance in obese individuals. Chemosphere 209:268–276
Heindel JJ, Blumberg B, Cave M, Machtinger R, Mantovani A, Mendez MA et al (2017) Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol 68:3–33
Committee ES (2013) Scientific opinion on the hazard assessment of endocrine disruptors: scientific criteria for identification of endocrine disruptors and appropriateness of existing test methods for assessing effects mediated by these substances on human health and the environment. EFSA J 11(3):3132
Tapia-Orozco N, Santiago-Toledo G, Barrón V, Espinosa-García AM, García-García JA, García-Arrazola R (2017) Environmental epigenomics: current approaches to assess epigenetic effects of endocrine disrupting compounds (EDC’s) on human health. Environ Toxicol Pharmacol 51:94–99
Govarts E, Iszatt N, Trnovec T, de Cock M, Eggesbø M, Murinova LP et al (2018) Prenatal exposure to endocrine disrupting chemicals and risk of being born small for gestational age: pooled analysis of seven European birth cohorts. Environ Int 115:267–278
Commission E. Avalaible from: http://ec.europa.eu
Khalil N, Chen A, Lee M (2014) Endocrine disruptive compounds and cardio-metabolic risk factors in children. Curr Opin Pharmacol 19:120–124
Duan Y, Wang L, Han L, Wang B, Sun H, Chen L et al (2017) Exposure to phthalates in patients with diabetes and its association with oxidative stress, adiponectin, and inflammatory cytokines. Environ Int 109:53–63
Zarean M, Keikha M, Poursafa P, Khalighinejad P, Amin M, Kelishadi R (2016) A systematic review on the adverse health effects of di-2-ethylhexyl phthalate. Environ Sci Pollut Res 23(24):24642–24693
Braun JM, Sathyanarayana S, Hauser R (2013) Phthalate exposure and children’s health. Curr Opin Pediatr 25(2):247–254
Dong R, Zhou T, Zhao S, Zhang H, Zhang M, Chen J et al (2017) Food consumption survey of Shanghai adults in 2012 and its associations with phthalate metabolites in urine. Environ Int 101:80–88
Katsikantami I, Sifakis S, Tzatzarakis MN, Vakonaki E, Kalantzi O-I, Tsatsakis AM et al (2016) A global assessment of phthalates burden and related links to health effects. Environ Int 97:212–236
Chen S-Y, Hwang J-S, Sung F-C, Lin C-Y, Hsieh C-J, Chen P-C et al (2017) Mono-2-ethylhexyl phthalate associated with insulin resistance and lower testosterone levels in a young population. Environ Pollut 225:112–117
Veiga-Lopez A, Pu Y, Gingrich J, Padmanabhan V (2018) Obesogenic endocrine disrupting chemicals: identifying knowledge gaps. Trends Endocrinol Metab 29:607–625
Windham GC, Zhang L, Gunier R, Croen LA, Grether JK (2006) Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco Bay area. Environ Health Perspect 114(9):1438–1444
Braun JM, Hauser R (2011) Bisphenol a and children’s health. Curr Opin Pediatr 23(2):233–239
Sabanayagam C, Teppala S, Shankar A (2013) Relationship between urinary bisphenol A levels and prediabetes among subjects free of diabetes. Acta Diabetol 50(4):625–631
Khalil N, Ebert JR, Wang L, Belcher S, Lee M, Czerwinski SA et al (2014) Bisphenol A and cardiometabolic risk factors in obese children. Sci Total Environ 470:726–732
Barraza L (2013) A new approach for regulating bisphenol A for the protection of the public's health. J Law Med Ethics 41:9–12
Annamalai J, Namasivayam V (2015) Endocrine disrupting chemicals in the atmosphere: their effects on humans and wildlife. Environ Int 76:78–97
Li L, Arnot J, Wania F (2018) Revisiting the contributions of far-and near-field routes to aggregate human exposure to polychlorinated biphenyls (PCBs). Environ Sci Technol 52:6974–6984
Louis C, Tinant G, Mignolet E, Thomé J-P, Debier C (2014) PCB-153 shows different dynamics of mobilisation from differentiated rat adipocytes during lipolysis in comparison with PCB-28 and PCB-118. PLoS One 9(9):e106495
Ejaz S, Akram W, Lim CW, Lee JJ, Hussain I (2004) Endocrine disrupting pesticides: a leading cause of cancer among rural people in Pakistan. Exp Oncol 26(2):98–105
Diggs DL, Huderson AC, Harris KL, Myers JN, Banks LD, Rekhadevi PV et al (2011) Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective. J Environ Sci Health C 29(4):324–357
Tairova ZM, Giessing AM, Hansen R, Andersen O (2009) 1-Hydroxypyrene as a biomarker of PAH exposure in the marine polychaete Nereis diversicolor. Mar Environ Res 67(1):38–46
Morville S, Delhomme O, Millet M (2011) Seasonal and diurnal variations of atmospheric PAH concentrations between rural, suburban and urban areas. Atmos Pollut Res 2(3):366–373
Maqbool F, Mostafalou S, Bahadar H, Abdollahi M (2016) Review of endocrine disorders associated with environmental toxicants and possible involved mechanisms. Life Sci 145:265–273
Duyzer J (2003) Pesticide concentrations in air and precipitation in the Netherlands. J Environ Monit 5(4):77N–80N
Sifakis S, Androutsopoulos VP, Tsatsakis AM, Spandidos DA (2017) Human exposure to endocrine disrupting chemicals: effects on the male and female reproductive systems. Environ Toxicol Pharmacol 51:56–70
Frye CA (2014) Endocrine-disrupting chemicals: elucidating our understanding of their role in sex and gender-relevant end points. Vitamins & Hormones, vol 94.: Elsevier, pp 41–98
Schug TT, Janesick A, Blumberg B, Heindel JJ (2011) Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol 127(3–5):204–215
Casals-Casas C, Desvergne B (2011) Endocrine disruptors: from endocrine to metabolic disruption. Annu Rev Physiol 73:135–162
Kelishadi R (2007) Childhood overweight, obesity, and the metabolic syndrome in developing countries. Epidemiol Rev 29(1):62–76
Heindel JJ, Newbold R, Schug TT (2015) Endocrine disruptors and obesity. Nat Rev Endocrinol 11(11):653–661
Shafei AE, Ramzy MM, Hegazy AI, Husseny AK, EL-hadary UG, Taha MM et al (2018) The molecular mechanisms of action of the endocrine disrupting chemical bisphenol A in the development of cancer. Gene 647:235–243
Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M (2012) Prediabetes: a high-risk state for diabetes development. Lancet 379(9833):2279–2290
Rancière F, Lyons JG, Loh VH, Botton J, Galloway T, Wang T et al (2015) Bisphenol A and the risk of cardiometabolic disorders: a systematic review with meta-analysis of the epidemiological evidence. Environ Health 14(1):46
Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 120(16):1640–1645
WHO. Cardiovascular diseases. Available from: http://www.whoint/nmh/publications/fact_sheet_cardiovascular_en.pdf
Liu C, Xu X, Huo X (2014) Anogenital distance and its application in environmental health research. Environ Sci Pollut Res 21(8):5457–5464
Zarean M, Keikha M, Feizi A, Kazemitabaee M, Kelishadi R (2019) The role of exposure to phthalates in variations of anogenital distance: a systematic review and meta-analysis. Environ Pollut 247:172–179
WHO. Cancers. Available from: https://www.whoint/nmh/publications/fact_sheet_cancers_en.pdf
WHO. Chronic respiratory diseases. Available from: https://www.whoint/?ReturnUrl=http%3a%2f%2fwwwwhoint%2fnmh%2fpublications%2ffact_sheet_respiratory_en.pdf
Norman RE, Carpenter DO, Scott J, Brune MN, Sly PD (2013) Environmental exposures: an underrecognized contribution to noncommunicable diseases. Rev Environ Health 28(1):59–65
Neel BA, Sargis RM (2011) The paradox of progress: environmental disruption of metabolism and the diabetes epidemic. Diabetes 60(7):1838–1848
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Zarean, M., Poursafa, P. (2019). The Role of Environmental Disruptor Chemicals in the Development of Non Communicable Disease. In: Kelishadi, R. (eds) Primordial Prevention of Non Communicable Disease. Advances in Experimental Medicine and Biology, vol 1121. Springer, Cham. https://doi.org/10.1007/978-3-030-10616-4_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-10616-4_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-10615-7
Online ISBN: 978-3-030-10616-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)